Clinical Trials in Atlanta

Showing 5001-5020 of 14,993 trials

Timing and Facilitation Effects of Theta-Burst Stimulation in the Reading and Language Networks

NCT06608680

The purpose of this study is to understand how transcranial magnetic stimulation affects how quickly, easily, and accurately a person read. Transcranial magnetic stimulation is a technique that uses magnetic fields to briefly affect how well certain brain regions function. The investigators would like to better understand how long the effects of transcranial magnetic stimulation occur in the reading system and at what point the effect is strongest in this system. The main questions it aims to answer are: 1. At what point after stimulation are the greatest effects on behavior seen 2. How excitatory and inhibitory stimulation affect behavior Researchers will compare stimulation types against a sham condition to see effects on reading and language behavior. Participants will be asked to * undergo reading, language, and cognitive testing * receive an MRI * receive TMS stimulation * perform language, reading, and motor tasks

ReadingLanguageControl Subjects

Georgia State University50 participantsStarted May 2023

Atlanta, Georgia, United States

COMPLETEDPhase 3< 1 mile

A Study of Sotatercept for the Treatment of Pulmonary Arterial Hypertension (MK-7962-003/A011-11)(STELLAR)

NCT04576988

The objectives of this study are to evaluate the efficacy and safety of sotatercept (MK-7962) treatment (plus background pulmonary arterial hypertension (PAH) therapy) versus placebo (plus background PAH therapy) at 24 weeks in adults with PAH. The primary hypothesis of the study is that the participants receiving sotatercept will have improved 6-minute walk distance (6MWD) at 24 weeks compared to participants receiving placebo.

Pulmonary Arterial Hypertension

Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA324 participantsStarted Jan 2021

Phoenix, Arizona, United States • Phoenix, Arizona, United States • Tucson, Arizona, United States +117 more locations

Timing and Facilitation Effects of Theta-Burst Stimulation in the Reading and Language Networks

A Study of Sotatercept for the Treatment of Pulmonary Arterial Hypertension (MK-7962-003/A011-11)(STELLAR)

Find Trials by Condition in Atlanta

Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Children, Known or Suspected to be Caused by Susceptible Gram-positive Organisms, Including MRSA

Engaging Staff to Improve COVID-19 Vaccination Response at Long-Term Care Facilities

Examination of Zinc, S-adenosylmethionine, and Combination Therapy Versus Placebo in Alcoholics

Study to Evaluate Safety, Tolerability and Efficacy of Saroglitazar Mg in Patients With Primary Biliary Cholangitis

S1314, Co-expression Extrapolation (COXEN) Program to Predict Chemotherapy Response in Patients With Bladder Cancer

A Study to Measure the Amount of Study Medicine in Blood in Adult Participants With COVID-19 and Severe Kidney Disease

Viz HCM (ECG Assist) Utilization Workflow Pilot

Investigating Otilimab in Patients With Severe Pulmonary COVID-19 Related Disease

A Study to Characterize the Outcomes of Olaparib Maintenance Monotherapy in Newly Diagnosed BRCAwt Ovarian Cancer

A Drug-Drug Interaction Study to Evaluate the Effect of Ripretinib on the Pharmacokinetics of a CYP2C8 Probe Substrate in Patients with Advanced GIST

Air Optix® Night and Day® Aqua Continuous Wear

A Randomized Phase 2 Trial of TAS-114 in Combination With S-1 Versus S-1

A Study to Evaluate Analgesic Efficacy and Safety of PRF-110 for Post-surgical Pain

Study of a Combination of GSK1795091 and Immunotherapies in Subjects With Advanced Solid Tumors

Pilot Trial of the RUBI Program for Autistic Adults

To Assess the Safety and Efficacy of SP-002 with Vismodegib for the Treatment of Locally Advanced Basal Cell Carcinoma

Gene Therapy Clinical Trial for the Treatment of Leber's Hereditary Optic Neuropathy Associated With ND1 Mutations

A Study to Evaluate the Efficacy, Safety, and Concentration of SNS812 in Mild to Moderate COVID-19 Patients